October 24, 2019
View Full PaperAtrial fibrillation ablation in patients with transthyretin cardiac amyloidosis
Structured PICO
Does atrial fibrillation ablation reduce mortality in patients with transthyretin cardiac amyloidosis?
P
Population
Patients with transthyretin cardiac amyloidosis (ATTR CA) and atrial fibrillation
I
Intervention
Atrial fibrillation ablation
O
Outcome
Mortalityhard clinical
Atrial fibrillation ablation is associated with reduced mortality in patients with ATTR cardiac amyloidosis, especially when performed early in the disease course.
Abstract
Atrial fibrillation ablation is associated with reduced mortality in ATTR CA and is most effective when performed earlier during the disease process.